Navigation Links
MAP Pharmaceuticals to Present Data on LEVADEX™ at the 63rd Annual Meeting of the American Academy of Neurology
Date:2/28/2011

MOUNTAIN VIEW, Calif., Feb. 28, 2011 /PRNewswire/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced that LEVADEX™ orally inhaled migraine therapy will be featured in one oral presentation and four poster presentations at the 63rd Annual Meeting of the American Academy of Neurology (AAN) in Honolulu, Hawaii April 9-16, 2011. A summary of the Company's AAN presentations is below, and the abstracts can be accessed at the AAN website at www.aan.com. LEVADEX is an investigational acute therapy for migraine that has completed Phase 3 clinical development.Utility of LEVADEX (MAP0004) in Situations Where Early Intervention Paradigm Is Impractical Session Info: Platform Session: April 12, 2011, 3:00-4:30 p.m. HASTPresentation Info: April 12, 2011 at 3:45 p.m. HASTPresentation #: 004An Open-Label, 2-Period, Crossover Study Comparing the Pharmacokinetics and Tolerability of LEVADEX (MAP0004, Orally Inhaled DHE) and Intravenous DHE (DHE45®) in Smoking and Non-Smoking Adult VolunteersSession Info: Poster Session 3: April 12, 2011, 2:00-6:00 p.m. HASTPoster #: 028A Randomized, Double-Blind, Placebo Controlled, Three-Period Crossover Study Comparing the Acute Effects of LEVADEX (MAP0004, Orally Inhaled DHE) and Intravenous DHE on Pulmonary Arterial Systolic PressureSession Info: Poster Session 3: April 12, 2011, 2:00-6:30 p.m. HASTPoster #: 029The Major Metabolite of Dihydroergotamine (DHE) after Oral Inhalation and IV Administration Does Not Significantly Contribute to the Pharmacologic ActivitySession Info: Poster Session 5: April 13, 2011, 2:00-6:30 p.m. HASTPoster #: 272Migraine Recurrence Rates: Case for Standardization of the DefinitionSession Info: Poster Session 5: April 13, 2011, 2:00-6:30 p.m. HASTPoster #: 285About LEVADEX™ LEVADEX is an investigational acute therapy for migraine that has completed Phase 3 clinical deve
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Savient Pharmaceuticals Announces U.S. Launch of KRYSTEXXA™; Reports Fourth Quarter and Year-End 2010 Financial Results
2. Auxilium Pharmaceuticals to Present at the 2011 Citi Annual Global Healthcare Conference
3. Cumberland Pharmaceuticals Appoints Tan Cheow Choon as Director of International Business
4. Anadys Pharmaceuticals to Report Fourth Quarter and Year-end 2010 Financial Results
5. UCLA and Sound Pharmaceuticals Identify a Key Hearing Regeneration Protein in the Human Inner Ear
6. JHP Pharmaceuticals Enters Another Multi-Year Contract Manufacturing Agreement
7. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Fourth Quarter and Full Year Financial Results
8. Inovio Pharmaceuticals to Present at Cowen & Co. Health Care Conference
9. Jazz Pharmaceuticals to Present at the Citi 2011 Global Health Care Conference in New York on March 1
10. Tarix Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Study of TXA127 Following Autologous Peripheral Blood Stem Cell Transplant
11. Idenix Pharmaceuticals to Present at an Upcoming Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... the leading health care supply chain expertise, analytics and ... national contracts that expand its portfolio to provide hospital ... These include manufacturer product and service agreements, as well ... IT consulting support. New Novation agreements ...
(Date:1/15/2014)... BreedIT Corp (OTC: BRDT), through its Israeli ... sophisticated agro-breeding solutions for plant breeders and researchers, today ... of directors appointed chemistry and pharmaceutical industry expert Dr. ... the board. From 1975 to 2012, Dr. ...
(Date:1/15/2014)... , Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... its Symphony® CGM System as a non-invasive, wireless continuous ... Doman , Executive Chairman and Interim CEO of Echo ... Tenth Annual Equity Conference. Mr. Doman ...
Breaking Medicine Technology:New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3
... Champions Biotechnology, Inc. (OTC ... with a predictive preclinical platform aimed at accelerating ... drugs, has established an exclusive licensing agreement with ... University,s wholly owned technology transfer company. The licensing ...
... Bellicum Pharmaceuticals, Inc. today announced $4.5 million in Series ... used to complete the company,s ongoing Phase I/IIa trial of ... to prepare for Phase IIb trials. The company anticipates reporting ... , The new funding brings the total raised to date ...
Cached Medicine Technology:Champions Biotechnology, Inc. Signs Exclusive Licensing Agreement with Ramot for TAR-1, a Novel Therapeutic for the Treatment of Cancer 2Champions Biotechnology, Inc. Signs Exclusive Licensing Agreement with Ramot for TAR-1, a Novel Therapeutic for the Treatment of Cancer 3Champions Biotechnology, Inc. Signs Exclusive Licensing Agreement with Ramot for TAR-1, a Novel Therapeutic for the Treatment of Cancer 4Bellicum Pharmaceuticals Announces $4.5 Million in New Funding 2
(Date:4/17/2014)... uncommon these days to find a colored ribbon representing a ... cancer. But what color ribbon does one think of with ... color, for many suffering from the disease, black may be ... study consisting of lung cancer patients, primarily smokers between the ... light on the stigma often felt by these patients, the ...
(Date:4/17/2014)... improves general blood flow and alleviates muscle soreness ... at the University of Illinois at Chicago. , ... in the Archives of Physical Medicine and ... function in people who had not exercised, suggesting ... their level of physical activity. , Improved circulation ...
(Date:4/17/2014)... found that India,s shocking rates of suicide are highest ... clinging to tiny smallholdings less than one hectare ... cotton and coffee, that are highly susceptible to global ... previous case studies that point to a crisis in ... of the nation,s economy during the 90s. Researchers say ...
(Date:4/17/2014)... April 17, 2014 Giving patients adrenaline after they suffer ... increase their prospects of surviving long-term, according to new ... number of patients who have a cardiac arrest get ... cardiac arrest for decades," said Dr. Steve Lin, an ... "Yet, despite advances in medical treatment, long-term survival rates ...
(Date:4/17/2014)... lost its status as the leading weapon against the ... life, with new research indicating it simply needs to ... use of the cheap anti-malarial drug chloroquine in treating ... of more than half a million people each year ... has developed resistance to chloroquine, but research carried out ...
Breaking Medicine News(10 mins):Health News:Unraveling the 'black ribbon' around lung cancer 2Health News:Massage therapy improves circulation, eases muscle soreness 2Health News:New evidence of suicide epidemic among India's 'marginalized' farmers 2Health News:New evidence of suicide epidemic among India's 'marginalized' farmers 3Health News:Adrenaline does little to increase patient's survival after cardiac arrest 2Health News:Scientists find new way to fight malaria drug resistance 2
... published this week in the New England Journal of ... patients with a specific genetic mutation benefit from the drug ... 15.9 months. In patients who responded, the drug stopped cancer ... with a BRAF V600 mutation, this drug is a breakthrough. ...
... emerging field of systems biology, UT Southwestern Medical Center researchers ... cell,s sense of direction and then confirmed those predictions in ... explain how mammalian cells establish the sense of direction necessary ... form of E. coli bacteria employ to hijack ...
... Mo. Many leading causes of death are ... activity. Adults in minority populations have lower levels ... deaths, according to the Department of Health & ... Missouri researchers found that minority adults who received ...
... By Steven Reinberg HealthDay Reporter , ... on Wednesday blocked implementation of an FDA mandate that ... images on packages of cigarettes. The proposed requirement ... set to kick in this September, would have emblazoned ...
... All children can benefit from going to preschool, especially those ... where parents don,t provide much mental stimulation, a new study ... from 600 families who were followed from age 2 until ... went to preschool did better once they started kindergarten than ...
... refuting a hypothesis can be as significant as proving ... elucidating how diseases proceed with a view toward preventing, ... scientists from spending precious years of effort exploring a ... Proceedings of the National Academy of Sciences , Munich-based ...
Cached Medicine News:Health News:Investigators predict, confirm how E. coli bacteria hijack cells' directional mechanism 2Health News:Fitness programs for minority adults lack cultural relevance, MU study finds 2Health News:Judge Blocks Plan for Graphic Cigarette Warnings 2Health News:Preschool Kids Best Prepared for Kindergarten: Study 2Health News:Observations refute widely held view on causal mechanism in ALS 2Health News:Observations refute widely held view on causal mechanism in ALS 3
Use the Mo Bio Vortex adapter to process multiple samples at the same time. The adapter holds tubes horizontally to increase cell lysis and mixing efficiency. Ideal for bead beating procedures....
... Mo Bio Vortex Adapter in conjunction with the ... Using the Mo Bio Vortex Adapter is ... Fast Prep machines which offer the same technology. ... centrifuge tubes at one time and will fit ...
... Combines BchiVac V-500 with Vacuum Controller ... controls vacuum levels from Compact Housing ... membrane vacuum pump designed to handle most vacuum ... use with up to two rotary evaporators ...
... V-500 with Vacuum Controller V-800 and water-cooled secondary ... Model V-500 is a powerful ... vacuum applications. Applications Ideally suited ... Laboratory vacuum source for instruments including ...
Medicine Products: